Results 171 to 180 of about 1,885,146 (393)

Committing to transparency to resist corruption [PDF]

This paper examines firms' incentives to commit to a transparent behavior (that precludes bribery) in a competitive procedure modeled as an asymmetric information beauty contest managed by a corrupt agent.
Ariane Lambert-Mogiliansky, Frédéric Koessler   +1 more
core  

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Bringing AI participation down to scale

Patterns
Summary: In 2023, OpenAI’s Democratic Inputs program funded 10 teams to design procedures for public participation in generative AI. In this perspective, we review the results of the project, drawing on interviews with some of the teams and our own ...
David Moats, Chandrima Ganguly
doaj  

Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study. [PDF]

Nat Commun
Sohai DK, Keller MD, Hanley PJ, Hoq F, Kukadiya D, Datar A, Reynolds E, Copertino DC, Lazarski C, McCann CD, Tanna J, Shibli A, Lang H, Zhang A, Chansky PA, Motta C, Huynh TT, Dwyer B, Wilson A, Lynch R, Mota TM, Conce Alberto WD, Brumme ZL, Kinloch NN, Cruz CRY, MacLaren Ehui L, Henn S, Brad Jones R, Bollard CM.   +28 more
europepmc   +1 more source

Going along with Defenses in Resistive Families

, 1959
Sidney Love, Herta Mayer
openalex   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

Proximity effect correction in electron beam lithography using a composite function model of electron scattering energy distribution. [PDF]

Discov Nano
Mao Q, Zhu J, Cheng X, Wang Z.
europepmc   +1 more source

DISCUSSION. ON THE CONSTRUCTION OF ARTILLERY, AND OTHER VESSELS, TO RESIST INTERNAL PRESSURE. [PDF]

G P BIDDER, J A LONGRIDGE, A LONGSDON, C H GREGORY, Benjamín Britten, Sir John Fox Burgoyne, John R. Anderson, SIR C FOX, F A ABEL, E A COWPER, C W SIEMENS, William M. Armstrong, W S MOORSOM, E L Wilmot, E TULLOH, W B ADAMS   +15 more
openalex   +1 more source

Acid - Resisting Metals [PDF]

, 1925

openalex   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source